Immunotherapy

Plotter
 
3. Treatment
any anti PD-1
nivolumab
pembrolizumab
any anti PD-L1
atezolizumab
durvalumab
any anti CTLA-4
ipilimumab
any immune checkpoint inhibitor therapy
Total: 0
Non-responders: 0
Responders: 0
4. Filters (optional)
5. Settings
Results
Please run the analysis first